Rich listers back stockpicking stars in $500m Hearts & Minds float

Magellan's Hamish Douglass will spearhead five of the country's best fund managers picking their top 15 stocks for a new $500 million listed investment company.

Patrick Durkin

Rich listers back stockpicking stars in $500m Hearts & Minds float

October 3, 2018
Magellan's Hamish Douglass will spearhead five of the country's best fund managers picking their top 15 stocks for a new $500 million listed investment company.
Read Transcript

Just because Magellan Financial Group's Hamish Douglass is picking stocks for charity, don't expect him not to make a truckload of money for Rich Listers like Mike Cannon-Brookes, Solomon Lew and the Stokes, Ainsworth, Lowy and Packer families.

Douglass will spearhead five of the country's best fund managers picking their top 15 stocks for a new $500 million listed investment company to list on the stock exchange on November 21. Another 10 stocks will be picked from fund managers presenting at the annual Sohn Hearts and Minds Investment Conference on November 16, including Geoff Wilson and Alex Waislitz.

The fund managers, directors and brokers involved have all waived their fees so that the listed investment vehicle can donate 1.5 per cent of net tangible assets, regardless of performance, every six months to support life-saving medical research, but are also determined to shoot the lights out for investors.

The listed investment vehicle known as HM1 was first revealed by Street Talk and is expected to open to the public on October 15 at $2.50 per share, after being backed by Rich Listers, who have already committed $175 million

"Fundamentally they are there because they think it's a great investment idea and they will make money from it with the comfort it is for a good cause, but they are not looking at this as a charitable donation," UBS chairman of investment banking in Australia Guy Fowler, who has been meeting with wealthy families over the past week, tells The Australian Financial Review.

 

Country's cream stock-pickers

The public will be able to invest alongside star stockpickers from Magellan, Caledonia, Cooper Investors, Paradice and Regal who will each pick their top three stocks along with the best 10 stock picks from the conference.

"People would normally be incredibly protective in the funds management industry and don't support other people but this shows the very best of this industry coming together," Mr Douglass, who is also investing his own money, tells The Australian Financial Review.

"Each of the fund managers will be picking their cream and putting them into a portfolio of 25 stocks which is completely unique, it is everyone's very best ideas in one concentrated portfolio.

"Our largest investment at the moment on the public record is Alphabet [the company formerly known as Google], if it is still our largest highest conviction portfolio position you would expect we would probably put that investment forward but there is some time to go between now and when the fund gets launched."

 

Serious returns

CEO of UBS Australia Matthew Grounds, who is expected to join Mr Fowler as a director of HM1, said it is both "a good investment" and raises money - expected to start at $7.5 million - for "some great causes" which include the Victor Chang Cardiac Research Institute, Black Dog Institute and the Charlie Teo Foundation. Mr Grounds and Mr Douglass sit on the Victor Chang board together.

"The beauty is some of these funds are not available to the public so this is really unique," Mr Grounds says. "The five core fund managers all have slightly different strategies but are putting up their best three ideas. There are no performance fees, just a base fee of 1.5 per cent and all of that money goes to medical research."

The stock recommendations from last year's conference were used by UBS used to set up a structured product seeded by a $10 million grant from Paul Ramsay's foundation and created the genesis of the idea for the LIC.

Recommendations last year included Caledonia Investments' Mike Messara's choice of US-based restaurant disrupter GrubHub, which has returned 126 per cent, and Regal Funds Management Philip King's choice of speech and technology services group Appen, which returned 148 per cent, compared to a 6 per cent return from the All Ords Index.

The investment vehicle also builds on the idea of fund manager Geoff Wilson, who will be joining the board of HM1 after he launched the Future Generation Investment Company which mandates Bennelong and Paradice to invest money on their behalf, with their fees also donated to charity.

Former Colonial First State CEO and now philanthropist Chris Cuffe is set to take the reins of HM1 as chairman while director of BT Financial Lorraine Berends, MH Carnegie and Sunsuper director Michael Traill and managing partner of Zenith Investment Partners David Wright expected to join Mr Grounds, Mr Fowler and Mr Wilson as directors.

 

Licensed by Copyright Agency. You must not copy this work without permission.

Just because Magellan Financial Group's Hamish Douglass is picking stocks for charity, don't expect him not to make a truckload of money for Rich Listers like Mike Cannon-Brookes, Solomon Lew and the Stokes, Ainsworth, Lowy and Packer families.

Douglass will spearhead five of the country's best fund managers picking their top 15 stocks for a new $500 million listed investment company to list on the stock exchange on November 21. Another 10 stocks will be picked from fund managers presenting at the annual Sohn Hearts and Minds Investment Conference on November 16, including Geoff Wilson and Alex Waislitz.

The fund managers, directors and brokers involved have all waived their fees so that the listed investment vehicle can donate 1.5 per cent of net tangible assets, regardless of performance, every six months to support life-saving medical research, but are also determined to shoot the lights out for investors.

The listed investment vehicle known as HM1 was first revealed by Street Talk and is expected to open to the public on October 15 at $2.50 per share, after being backed by Rich Listers, who have already committed $175 million

"Fundamentally they are there because they think it's a great investment idea and they will make money from it with the comfort it is for a good cause, but they are not looking at this as a charitable donation," UBS chairman of investment banking in Australia Guy Fowler, who has been meeting with wealthy families over the past week, tells The Australian Financial Review.

 

Country's cream stock-pickers

The public will be able to invest alongside star stockpickers from Magellan, Caledonia, Cooper Investors, Paradice and Regal who will each pick their top three stocks along with the best 10 stock picks from the conference.

"People would normally be incredibly protective in the funds management industry and don't support other people but this shows the very best of this industry coming together," Mr Douglass, who is also investing his own money, tells The Australian Financial Review.

"Each of the fund managers will be picking their cream and putting them into a portfolio of 25 stocks which is completely unique, it is everyone's very best ideas in one concentrated portfolio.

"Our largest investment at the moment on the public record is Alphabet [the company formerly known as Google], if it is still our largest highest conviction portfolio position you would expect we would probably put that investment forward but there is some time to go between now and when the fund gets launched."

 

Serious returns

CEO of UBS Australia Matthew Grounds, who is expected to join Mr Fowler as a director of HM1, said it is both "a good investment" and raises money - expected to start at $7.5 million - for "some great causes" which include the Victor Chang Cardiac Research Institute, Black Dog Institute and the Charlie Teo Foundation. Mr Grounds and Mr Douglass sit on the Victor Chang board together.

"The beauty is some of these funds are not available to the public so this is really unique," Mr Grounds says. "The five core fund managers all have slightly different strategies but are putting up their best three ideas. There are no performance fees, just a base fee of 1.5 per cent and all of that money goes to medical research."

The stock recommendations from last year's conference were used by UBS used to set up a structured product seeded by a $10 million grant from Paul Ramsay's foundation and created the genesis of the idea for the LIC.

Recommendations last year included Caledonia Investments' Mike Messara's choice of US-based restaurant disrupter GrubHub, which has returned 126 per cent, and Regal Funds Management Philip King's choice of speech and technology services group Appen, which returned 148 per cent, compared to a 6 per cent return from the All Ords Index.

The investment vehicle also builds on the idea of fund manager Geoff Wilson, who will be joining the board of HM1 after he launched the Future Generation Investment Company which mandates Bennelong and Paradice to invest money on their behalf, with their fees also donated to charity.

Former Colonial First State CEO and now philanthropist Chris Cuffe is set to take the reins of HM1 as chairman while director of BT Financial Lorraine Berends, MH Carnegie and Sunsuper director Michael Traill and managing partner of Zenith Investment Partners David Wright expected to join Mr Grounds, Mr Fowler and Mr Wilson as directors.

 

Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by Australian Financial Review, published on Oct 03, 2018. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
May 19, 2025

HM1 Leadership Restructure

The Board has announced the restructure of its leadership, transitioning from a full-time CEO role to a more streamlined model. As a result, Brett Jollie will step down as CEO and Richard Howes will be appointed to a new part-time role of Managing Director.

Read More
June 12, 2025

Coeur Mining – a high-conviction precious metals re-rating story

Coeur Mining provides access to precious metals production in politically stable jurisdictions, with potential for operational and valuation upside.

Read More
March 10, 2025

Reporting Season Insights: HM1 Core Portfolio Holdings

We spoke to our dedicated fund managers for an update on some of our major portfolio holdings following reporting season.

Read More
February 20, 2025

Significant increase in profit and increased fully franked dividend

We're pleased to declare an increased half-year fully franked dividend of 8.0 cents per share payable in April 2025.

Read More
December 10, 2024

Professor Jane Butler: Sparking Hope for Spinal Cord Injuries

In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.

Read More
impact-podcasts
December 5, 2024

HM1 CEO Succession

Hearts and Minds Investments Limited advises that Paul Rayson intends to retire from the position of Chief Executive Officer, effective 19 February 2025.

Read More
Chris Cuffe, chairman of Hearts and Minds Investments, with chief investment officer Charlie Lanchester. Picture: John FederChris Cuffe, chairman of Hearts and Minds Investments, with chief investment officer Charlie Lanchester. Picture: John FederChris Cuffe, chairman of Hearts and Minds Investments, with chief investment officer Charlie Lanchester. Picture: John FederChris Cuffe, chairman of Hearts and Minds Investments, with chief investment officer Charlie Lanchester. Picture: John Feder
November 14, 2024

Sohn Hearts & Minds Investments fund targets $1.5bn valuation

‍Hearts & Minds Investments chair Chris Cuffe is hoping for HM1 to grow to more than $1.5bn in the next five years.

Read More
September 24, 2024

Asian Market Potential with Tom Naughton of Prusik

CIO Charlie Lancaster sits down with Tom Naughton, CIO of Prusik Investment Mgmt. Tom shares his investment philosophy, the opportunities and challenges in Asian markets, and how his 2023 conference stock pick, Swire Pacific (0019.HK), delivered an impressive 30% return.

Read More
investing
September 6, 2024

Exploring HM1 Top Stocks: Key Insights from Reporting Season

We have just come to the end of reporting season and the fund managers of our major portfolio holdings gave us their insights into the latest results of our key holdings.

Read More
September 4, 2024

Building Hearts and Minds with Co-Founders Matthew Grounds and Guy Fowler

In this episode, co-founders Matthew Grounds AM and Guy Fowler OAM discuss their journey in building Hearts & Minds and its philanthropic model that has donated over $70 million to medical research.

Read More
investing
June 25, 2024

Navigating the Resource Sector with Jeremy Bond of Terra Capital

In this episode, we chat with Jeremy Bond, Founder of Terra Capital and HM1 Conference Fund Manager. Tune in for insights into the world of resource investments and the exciting opportunities that lie ahead.

Read More
investing
June 11, 2024

Prof. Nadia Badawi on Cerebral Palsy Breakthroughs and Neonatal Care

Dive deep into the groundbreaking work of Professor Nadia Badawi, an internationally recognised neonatologist and expert in Cerebral Palsy.

Read More
impact-podcasts
May 28, 2024

Investment Insights: Rikki Bannan on Top Picks and Trends

Join us for an engaging episode featuring Rikki Bannan, Portfolio Manager of IFM Investors and HM1 Conference Fund Manager. This episode explores Rikki's career journey, investment strategies, and her 2023 conference stock pick, Telix Pharmaceuticals (ASX.TLX).

Read More
investing
March 7, 2024

Exploring HM1 Stocks: Key Insights from Reporting Season

We asked our fund managers for an update on how some of our key positions are performing off the back of the reporting season. Overall, it was a good period for the fund with some good moves to the upside.

Read More
February 6, 2024

Stock Story: ResMed

This month we take a deep dive into ResMed - one of the conference stocks within the fund that was astutely picked by Chris Kourtis of Ellerston Capital.

Read More
December 10, 2024

Professor Jane Butler: Sparking Hope for Spinal Cord Injuries

In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.

Read More
impact-podcasts
September 24, 2024

Asian Market Potential with Tom Naughton of Prusik

CIO Charlie Lancaster sits down with Tom Naughton, CIO of Prusik Investment Mgmt. Tom shares his investment philosophy, the opportunities and challenges in Asian markets, and how his 2023 conference stock pick, Swire Pacific (0019.HK), delivered an impressive 30% return.

Read More
investing
September 4, 2024

Building Hearts and Minds with Co-Founders Matthew Grounds and Guy Fowler

In this episode, co-founders Matthew Grounds AM and Guy Fowler OAM discuss their journey in building Hearts & Minds and its philanthropic model that has donated over $70 million to medical research.

Read More
investing
June 25, 2024

Navigating the Resource Sector with Jeremy Bond of Terra Capital

In this episode, we chat with Jeremy Bond, Founder of Terra Capital and HM1 Conference Fund Manager. Tune in for insights into the world of resource investments and the exciting opportunities that lie ahead.

Read More
investing
June 11, 2024

Prof. Nadia Badawi on Cerebral Palsy Breakthroughs and Neonatal Care

Dive deep into the groundbreaking work of Professor Nadia Badawi, an internationally recognised neonatologist and expert in Cerebral Palsy.

Read More
impact-podcasts
May 28, 2024

Investment Insights: Rikki Bannan on Top Picks and Trends

Join us for an engaging episode featuring Rikki Bannan, Portfolio Manager of IFM Investors and HM1 Conference Fund Manager. This episode explores Rikki's career journey, investment strategies, and her 2023 conference stock pick, Telix Pharmaceuticals (ASX.TLX).

Read More
investing
December 6, 2023

Peter Cooper talks building and instilling a culture of humility and excellence

In this episode, our guest is the renowned investor, Peter Cooper, founder and Chief Investment Officer of Cooper Investors (Core Fund Manager). A founding supporter of Hearts and Minds, Peter is a staunch advocate of our model and its philanthropic purpose, actively engaging in every facet of Hearts and Minds.

Read More
investing
November 28, 2023

Jun Bei Liu on her high conviction investment strategy

In this episode, HM1 Chief Investment Officer Charlie Lanchester is joined by Jun Bei Liu. Jun Bei is the Portfolio Manager of Tribeca’s Alpha Plus Fund and since taking over managing the Fund, she has quadrupled AUM.

Read More
investing
November 21, 2023

The world of rare genetic disease research

In this episode, we speak to Associate Professor Gina Ravenscroft. Gina is an Associate Professor in Neurogenetics at the Harry Perkins Institute of Medical Research in Perth. Her research interests are in rare genetic diseases, with a particular focus on neurogenetic diseases in babies and children.

Read More
impact-podcasts
November 14, 2023

Learn what makes a high conviction investment and how to avoid short-term noise

In this episode, our Core Fund Manager Magellan shares how they select top stocks for the HM1 portfolio.

Read More
investing
November 7, 2023

Delve into the world of kids critical care and trauma research

In thie episode, we are joined by Dr. Marino Festa, or Rino for short. He is the Medical Director of NSW Kids ECMO Referral Service and a senior specialist in Paediatric Intensive Care at Children’s Hospital at Westmead.

Read More
impact-podcasts
October 31, 2023

Where Regal's Phil King is searching for opportunities

HM1's CIO, Charlie Lanchester, talks to Phil King of Regal Funds about his passion for stocks, his ongoing search for opportunities, and some of the sectors he’s excited by right now. Phil King of Regal Funds, has been a tremendous supporter of Hearts & Minds since the beginning.

Read More
investing
October 24, 2023

Preventing recurrent miscarriages and birth defects

In this episode, CEO Paul Rayson is joined by renowned biomedical researcher Professor Sally Dunwoodie. Prof. Dunwoodie's groundbreaking work has revolutionised clinical practices and enabled genetic diagnostic tests worldwide. In 2017, her team achieved a double breakthrough with the potential to prevent recurrent miscarriages and various birth defects.

Read More
impact-podcasts
October 17, 2023

Nick Griffin on how he finds global winners

In this episode, CIO Charlie Lanchester chats with Nick Griffin, the founding partner and CIO of Munro Partners, one of HM1's Core Fund Managers. They go over his career to date, reflect on the lessons he’s learned, and trace the decisions that led to him starting Munro.

Read More
investing
October 10, 2023

How A/Prof Matt Call is teaching our body to kill cancer

In this episode, CEO Paul Rayson is joined by WEHI’s Associate Professor Matt Call to talk about his incredible research. Matt’s team teaches and trains the body's own immune cells to target and kill cancer cells.

Read More
impact-podcasts

No results found.

Please try a different search keyword or filter.